Concepedia

Michael Hedvat

MH

12

Publications

1.3K

Citations

11

H-Index

2004

Active since

Affiliations

Virginia Commonwealth University(Current)

City of Hope

Beckman Research Institute

City Of Hope National Medical Center

Washington University in St. Louis

Michael Hedvat is an author at Virginia Commonwealth University specializing in cell biology, medicine, and cell signaling.

ORCID

Top concepts

Publications per year

2004–2024

12

Publications

12

The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors

Michael Hedvat, Dennis Huszar, Andreas Herrmann et al. · Cancer Cell · 2009 · 526 citations · Full text

, , +8

Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to <i>mda</i> -7/IL-24–mediated toxicity

Rupesh Dash, Belal Azab, Bridget A. Quinn et al. · Proceedings of the National Academy of Sciences · 2011 · 123 citations

Sorafenib Induces Growth Arrest and Apoptosis of Human Glioblastoma Cells through the Dephosphorylation of Signal Transducers and Activators of Transcription 3

Fan Yang, Christine E. Brown, Ralf Buettner et al. · Molecular Cancer Therapeutics · 2010 · 117 citations · Full text

Antiangiogenic and Antimetastatic Activity of JAK Inhibitor AZD1480

Xin Hong, Andreas Herrmann, Karen L. Reckamp et al. · Cancer Research · 2011 · 112 citations · Full text

, , +17

Sunitinib Induces Apoptosis and Growth Arrest of Medulloblastoma Tumor Cells by Inhibiting STAT3 and AKT Signaling Pathways

Fan Yang, Veronica Jové, Xin Hong et al. · Molecular Cancer Research · 2010 · 101 citations · Full text

Rows per page

1–5 of 12